L
ight plays a key role in the living world. It serves as a source of energy through photosynthesis, makes sight possible, and regulates circadian rhythms. During evolution, organisms from bacteria to higher mammals elaborate various mechanisms to sense and respond to light, which manipulates their behavior. The use of light as a trigger is particularly attractive as a means of controlling biological processes at will, because light is noninvasive and can be manipulated both temporally (from microseconds) and spatially (microns) (1) . In this issue of PNAS, Schierling et al. (2) demonstrate the possibility of controlling the enzymatic activity of the restriction endonuclease PvuII by light.
Restriction endonucleases are molecular scissors that recognize short DNA sequences usually 4-8 bp in length and cut the phosphodiester bond within or close to their target sites to generate a doublestranded break. To manipulate the catalytic activity of the orthodox restriction endonuclease PvuII by light, a previous study exploited a well-known feature of the photosensitive azobenzene derivative to reversibly isomerize between trans and cis forms under the influence of light (Fig. 1A) (3) . Under illumination by UV light at 366 nm, the azobenzene in trans configuration is converted to cis isomer, resulting in an end-to-end distance change. This geometry change of the azobenzene moiety is reversible, because illumination by blue light (or thermal relaxation) results in a cis to trans configuration transition. To act as a reversible photoswitch that controls protein activity, one isomeric form of the azobenzene should be able to lock the enzyme in the inactive "off" state, and the other form should be able to lock the enzyme in the active "on" state (Fig. 1A) . For this to occur, the bifunctional azobenzene derivative must be attached to the protein structural components, to allow transmittal of the change in switch conformation to the substrate-binding site or the catalytic center.
Because the attachment sites, which ensure tight coupling between cross-linker photoisomerization and protein conformational change, are difficult to predict, the optimal switch position must be identified experimentally. Schierling et al. (2) used a Cys-selective azobenzene derivative to install the cross-linker onto proteins bearing two surface-exposed Cys residues.
Cys residues can be easily introduced into the protein via site-directed mutagenesis, enabling scanning for suitable cross-linker attachment positions on the protein surface. In the case of the PvuII restriction endonuclease, Schierling et al. engineered more than 30 protein variants, each containing two or four Cys residues for the bifunctional azobenzene cross-linker attachment. Specifically, eight different sets of Cys residue pairs located on the surface of the PvuII dimer or a single chain variant (scPvuII) were probed as a cross-linker attachment sites to identify positions where the installed switch has
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the most prominent effect on catalytic activity. Furthermore, additional (nonCys) mutations at the functionally important regions had to be introduced to fine tune the effect of the photoswitch on the PvuII activity. To purify cross-linked variants from the reaction side-products, Schierling et al. developed an elegant purification scheme that includes the chemical modification step to introduce an extra negative charge into the side products containing unreacted maleimide groups, followed by anion-exchange chromatography. Using mass-spectrometry analysis, the authors demonstrated that cross-linking by the bifunctional azobenzene derivative occurred at specific positions of the PvuII protein.
The best photoswitchable PvuII variant, which had two azobenzene cross-links near the active site in each domain of the scPvuII form on the background of an additional mutation, modulated its DNA cleavage activity by a factor of up to 16 in response to illumination with UV and blue light. Thus, Schierling et al. provide a proofof-principle demonstration that the catalytic activity of restriction endonuclease can be reversibly controlled by light. They show that the azobenzene photoswitch toggles PvuII between active and inactive states under catalytic conditions in real time (within seconds), and also that the cross-linked form of PvuII with azobenzene in trans configuration has reduced cleavage activity at miscognate sites compared with the WT variant.
The reversible changes in enzymatic activity in response to light have been demonstrated previously for various proteins (4, 5) . So why is the photoswitchable site-specific PvuII endonuclease so exciting? A growing number of reports address the potential of zinc-finger nucleases (ZFNs), homing endonucleases, and engineered restriction enzymes as molecular tools for precise genome surgery (6, 7). Molecular scissors are used to cut DNA at a single site in the vicinity of the defective gene, followed by in trans supply of the correct gene copy to be integrated into the genome by an endogenous mechanism of site-specific recombination. The precise cleavage at a desired site is a key prerequisite for this method; thus, restriction endonucleases, homing endonucleases, and ZFNs are reengineered into "meganucleases," which are programmed to cut at a single site within the entire genome (6) (7) (8) (9) (10) . This method has been used to target dozens of genes in nematodes, zebrafish, and plant and mammalian (including human stem) cells (6, 11, 12) . Specifically, meganucleases have been reported to target genes related to severe combined immunodeficiency (SCID) (13) , xeroderma pigmentosum (XP) (14) , and HIV-1 infection (15) .
Treatment of cells with engineered meganucleases often induces toxicity, presumably due to the limited chromosome cleavage at the nonspecific sites (off-targets) (8, (15) (16) (17) . Such cleavage can result in deleterious mutations due to, for example, the inaccurate repair of the double-stranded breaks through nonhomologous end-joining. Strategies to reduce off-target cleavage by the engineered meganucleases (particularly ZFNs) include (i) controlling protein expression level (17) , (ii) fine tuning the specificity of the target recognition module (18) , and (iii) generating heterodimeric ZFNs (8, 19) . 
